2010
DOI: 10.1111/j.1756-5391.2010.01058.x
|View full text |Cite
|
Sign up to set email alerts
|

Avoiding adverse drug reactions to Chinese medicine injections

Abstract: A total of 109 varieties of Chinese medicine injections (CMI) have been approved by the State Food and Drug Administration of China, all of which have the potential to induce adverse drug reactions (ADRs). Major ADRs include systemic anaphylaxis, anaphylactic shock, acute intravascular hemolysis, hepatorenal damage, skin lesion, cardiac damage, respiratory system injury, and gastrointestinal disorders. Contributing factors of ADRs include healthcare workers' inadequate attention to ADRs of CMI, complex ingredi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
11
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 0 publications
0
11
0
Order By: Relevance
“…Our results suggest that the death numbers in clinics (Wang et al, 2004) are proportional to the severity of proarrhythmic risk of SHL, QKL and YZH found in this study. Currently, the adverse drug reactions caused by CHIs are thought to be attributed to allergic reactions and misuse in clinics (Li, 2010;Wang et al, 2010aWang et al, , 2010bZhang et al, 2010).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Our results suggest that the death numbers in clinics (Wang et al, 2004) are proportional to the severity of proarrhythmic risk of SHL, QKL and YZH found in this study. Currently, the adverse drug reactions caused by CHIs are thought to be attributed to allergic reactions and misuse in clinics (Li, 2010;Wang et al, 2010aWang et al, , 2010bZhang et al, 2010).…”
Section: Discussionmentioning
confidence: 99%
“…Since 1954, the State Food and Drug Administration (SFDA) of China has officially approved 109 CHIs for clinical use (Li, 2010). These CHIs (liquid or powder forms) are used clinically in China as putative therapies for a variety of diseases (including but not limited to bacterial and viral infections, cardiovascular and cerebrovascular dysfunction, cancer and rheumatoid arthritis; Zhou et al, 2006a).…”
Section: Introductionmentioning
confidence: 98%
“…Now the unconventional intravenous injection of herbal preparations bypassing the gastrointestinal tract has caused some allergic reaction in some patients, which is relatively uncommon if the properly prepared herbs are taken by mouth. In fact, a total of 109 varieties of Chinese medicine injections have been approved by the State Food and Drug Administration of China, all of which have the potential to induce adverse drug reactions that include systemic anaphylaxis, anaphylactic shock, acute intravascular hemolysis, hepatorenal damage, skin lesions, cardiac damage, respiratory distress, and GI disorders [12]. Furthermore, the tendency for consumers to use multiple unprepared herbs in conjunction with one another and in addition to prescription medications is problematic as most consumers and, in fact, most physicians and pharmacists are unaware of their potential drug interactions.…”
Section: Discussionmentioning
confidence: 99%
“…However, 5CQA has to be used correctly because the intramuscular application of this compound can induce myotoxicity, which can aggravate the patient's symptoms. There are several reports of adverse effects from the use of natural compounds, and many of these effects depend on the administration route of the compound [39]. …”
Section: Discussionmentioning
confidence: 99%